Renal Physiology for the Boards - Melanie P. Hoenig, MD

Basic Concepts of Immunology in Autoimmune Kidney Disease - Ramon G. Bonegio, MD

Question and Answer Session - Faculty

Renal Pathology in 2021: Part 1 Nephritic Conditions - Helmut G. Rennke, MD

Renal Pathology in 2021: Part 2 - Astrid Weins, MD, PhD

Current Approaches to Urine Sediment Analysis - Martina M. McGrath, MD

Question and Answer Session - Faculty

IgA Nephropathy - Gerald B. Appel, MD

Membranous Nephropathy - Laurence H. Beck, Jr., MD, PhD

ANCA Vasculitis - John L. Niles, MD

Question and Answer Session - Faculty

Update on Lupus Nephritis - Gerald B. Appel, MD

Metabolic Management of Kidney Stones - Gary C. Curhan, MD, ScD

Anemia Management: Update and Best Practices - Ajay K. Singh, MBBS, FRCP (UK), MBA

Question and Answer Session - Faculty

Glomerulonephritis: Questions & Answers Session - Gerald B. Appel, MD

Must-Know Clinical Images in Nephrology - Ajay K.. Singh, MBBS, FRCP (UK), MBA

Must-Know Board Zebras - Emily S. Robinson, MD, MPH

Nephrology Board Review Practice 1 - Finnian R. McCausland, MB BCh, MMSc, FRCPI

Nephrology Board Review Practice 2 - Mallika Mendu, MD, MBA

Hyponatremia and Hypernatremia - Sodium Disorders - David B. Mount, MD

Hypokalemia and Hyperkalemia - Potassium Disorders - David B. Mount, MD

Question and Answer Session - Faculty

Acid-Base Disorders Part I - Anion Gap Metabolic Acidosis - Alan S.L. Yu, MB, BChir

Acid-Base Disorders II - Non-Gap Acidosis and Metabolic Alkalosis - Alan S.L. Yu, MB, BChir

Question and Answer Session - Faculty

Pregnancy and Renal Disease - Ravi I. Thadhani, MD, MPH

Treating Renal Patients with Rituximab in the Era of COVID-19 - David B. Mount, MD

Genetics and Kidney Disease - Friedhelm Hildebrandt, MD

Update on Polycystic Kidney Disease - Cristian Riella, MD

Question and Answer Session - Faculty

Pediatric Nephrology - Michael J.G. Somers, MD

Genetics: How to Integrate It into Practice - Ali Gharavi, MD

Social Determinants/Disparities in Renal Disease - Winfred W. Williams, Jr., MD

Question and Answer Session - Faculty

Electrolytes and Acid-Base Practice for the Boards - Part 1 - Alan S.L. Yu, MB, BChir

Electrolytes and Acid-Base Practice for the Boards - Part 2 - Alan S.L. Yu, MB, BChir

Chronic Kidney Disease in the Community: Meeting Them Where They Are - Li-Li Hsiao, MD, PhD, FACP

SPECIAL LECTURE — End-Stage Renal Disease in Areas of Armed Conflict: Challenges and Solutions - Sahar Koubar, MD

Why Do We Reject a Transplant? - Jamil R. Azzi, MD

Transplant Immunosuppression for the Boards - Steven Gabardi, PharmD, BCPS, FAST, FCCP

Question and Answer Session - Faculty

Immunological Assessment Pre and Post Transplant - Melissa Y. Yeung, MD and Indira Guleria, PhD

Early Post-Transplant Management - Anil K. Chandraker, MD

Question and Answer Session - Faculty

Evaluation of the Kidney Living Donor - Kassem Safa, MD

Late Loss of the Kidney Transplant - Andrew M. Siedlecki, MD

Infections in Transplant Recipients - Sarah P. Hammond, MD

Monitoring Kidney Transplant Patients: Beyond Creatinine - Saif Abdulkarim Muhsin, MB BCh

Pre-Transplant Surgical Evaluation of Recipients - Jamil R. Azzi, MD

Question and Answer Session - Faculty

Poisonings and Intoxications: What a Nephrologist Needs to Know - Timothy B. Erickson, MD

Late Post-Transplant Medical Complications - Leonardo V. Riella, MD, PhD

Hemolytic Uremic Syndrome (HUS) and Thrombotic Thrombocytopenic Purpura (TTP) - Jean M. Francis, MD

Geriatric Nephrology - Ernest I. Mandel, MD

COVID-19 Vaccination Response in Transplant Patients - Ann Woolley, MD

Immunologic Basis of Kidney Disease - Vivek Kasinath, MD

Use of Checkpoint Inhibitors in Kidney Transplant Recipients - Naoka Murakami, MD, PhD

Pre-Transplant Surgical Evaluation of Recipients - Sayeed Malek, MD

Transplant Cases: Board Review Practice - Melissa Y. Yeung, MD and Edgar L. Milford, Jr., MD

Transplant Board Review - Anil K. Chandraker, MD

Pathophysiology and Treatment of Diabetic Kidney Disease - Gearoid M. McMahon, MB BCh

Management of Hypertension after SPRINT - Richard J. Glassock, MD

Question and Answer Session - Faculty

Secondary Hypertension: Primary Aldosteronism and Pheochromocytoma - Anand Vaidya, MD, MMSc

Cardiorenal Syndrome - Finnian R. McCausland, MB BCh, MMSc, FRCPI

Liver and the Kidney - Andrew S. Allegretti, MD, MSc

Question and Answer Session - Faculty

Update on Renovascular Disease - Joseph M. Garasic, MD

Pathophysiology of Acute Kidney Injury - Joseph V. Bonventre, MD, PhD

Acute Kidney Injury Syndromes - Alice M. Sheridan, MD

ICU Nephrology and Continuous Renal Replacement Therapies - David J.R. Steele, MB BCh

Question and Answer Session - Faculty

Cancer and Acute Kidney Injury - Albert Q. Lam, MD

Paraprotein Induced Kidney Injury - Albert Q. Lam, MD

FSGS: A Lesion, Not a Disease - Richard J. Glassock, MD

Interstitial Nephritis: Overview for the Boards - Julie M. Paik, MD, ScD, MPH

APOL1 and Kidney Disease - Martin R. Pollak, MD

Question and Answer Session - Faculty

Dialysis Dosing - J. Kevin Tucker, MD

Mineral and Bone Disease - David Bushinsky, MD

Question and Answer Session - Faculty

Dialysis: A Case-Based Clinical Review and Update - J. Kevin Tucker, MD

Pearls in Mineral and Bone Disease - David Bushinsky, MD

Chronic Kidney Disease Epidemiology: A 2021 Update - Gearoid M. McMahon, MB BCh

Question and Answer Session - Faculty

Peritoneal Dialysis - Joanne M. Bargman, MD, FRCPC

Peritoneal Dialysis Complications - Joanne M. Bargman, MD, FRCPC

COVID-19 and Kidney Disease - Daniel Batlle, MD

Mesoamerican Nephropathy - Ricardo Correa-Rotter, MD

Dialysis Vascular Access: Assessment and Complications - Dirk M. Hentschel, MD

Renal Ultrasound for the Clinical Nephrologist - Adina S. Voiculescu, MD

Question and Answer Session - Faculty